$1.70
0.03[1.80%]
Last update: 8:32AM Get Real Time Here
Checkpoint Therapeutics
(NASDAQ:CKPT)Checkpoint Therapeutics Stock (NASDAQ:CKPT), Quotes and News Summary
Checkpoint Therapeutics Stock (NASDAQ: CKPT) stock price, news, charts, stock research, profile.
| Open | $1.680 |
| Close | - |
| Volume / Avg. | 122.951K / 506.346K |
| Day Range | 1.640 - 1.720 |
| 52 Wk Range | 1.300 - 3.620 |
| Market Cap | $60.667M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 36 |
| Short Interest | 11.59% |
| Days to Cover | 9.64 |
Recent News
No news found
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Checkpoint Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It foc...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Checkpoint Therapeutics (CKPT) stock?
You can purchase shares of Checkpoint Therapeutics (NASDAQ: CKPT) through any online brokerage.
Who are Checkpoint Therapeutics's (CKPT) competitors?
Other companies in Checkpoint Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Vaxxinity (NASDAQ:VAXX), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS) and Immuneering (NASDAQ:IMRX).
What is the target price for Checkpoint Therapeutics (CKPT) stock?
The latest price target for Checkpoint Therapeutics (NASDAQ: CKPT) was reported by HC Wainwright & Co. on Friday, March 22, 2024. The analyst firm set a price target for 34.00 expecting CKPT to rise to within 12 months (a possible 1900.59% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Checkpoint Therapeutics (CKPT)?
The stock price for Checkpoint Therapeutics (NASDAQ: CKPT) is $1.6995 last updated Today at April 18, 2024 at 10:45 AM EDT.
Does Checkpoint Therapeutics (CKPT) pay a dividend?
There are no upcoming dividends for Checkpoint Therapeutics.
When is Checkpoint Therapeutics (NASDAQ:CKPT) reporting earnings?
Checkpoint Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.
Is Checkpoint Therapeutics (CKPT) going to split?
There is no upcoming split for Checkpoint Therapeutics.
What sector and industry does Checkpoint Therapeutics (CKPT) operate in?
Checkpoint Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.